Systematic review finds sugammadex reduces urinary retention after inguinal hernia repair, suggesting its use as a preferred treatment.
Sugammadex is associated with a significantly lower risk of POUR following IHR when compared to other medications for neuromuscular blockade reversal following IHR. Despite its higher cost and decreased availability in some centers, the use of Sugammadex should be strongly considered as the preferred option to prevent POUR and minimize the need for hospital readmissions.
No takes yet. Share an insight, caveat, or question.
Rasador et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: